An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects

Pediatric Nephrology ◽

10.1007/s00467-012-2186-9 ◽

2012 ◽

Vol 27 (10) ◽

pp. 1953-1959 ◽

Author(s):

Desmond Padhi ◽

Craig B. Langman ◽

Sahar Fathallah-Shaykh ◽

Bradley A. Warady ◽

Isidro B. Salusky ◽

...

Keyword(s):

Single Dose ◽

Open Label Study ◽

Label Study ◽

Pediatric Dialysis

Download Full-text

A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis

Journal of Women s Health ◽

10.1089/jwh.2017.6500 ◽

2018 ◽

Vol 27 (4) ◽

pp. 492-497 ◽

Author(s):

Steven E. Chavoustie ◽

Janet K. Gersten ◽

Milroy J. Samuel ◽

Jane R. Schwebke

Keyword(s):

Single Dose ◽

Bacterial Vaginosis ◽

Adolescent Girls ◽

Phase 3 ◽

Open Label Study ◽

Download Full-text

Pharmacokinetic properties of lansoprazole (30-mg enteric-coated capsules) and its metabolites: A single-dose, open-label study in healthy Chinese male subjects

Current Therapeutic Research ◽

10.1016/j.curtheres.2009.05.002 ◽

2009 ◽

Vol 70 (3) ◽

pp. 228-239 ◽

Author(s):

Min Song ◽

Xuan Gao ◽

Tai-Jun Hang ◽

Ai-Dong Wen

Keyword(s):

Single Dose ◽

Open Label Study ◽

Label Study ◽

Pharmacokinetic Properties ◽

Healthy Chinese ◽

Enteric Coated ◽

Male Subjects ◽

Download Full-text

Single-Dose, Open-Label Study of the Differences in Pharmacokinetics of Colchicine in Subjects with Renal Impairment, Including End-Stage Renal Disease

Clinical Drug Investigation ◽

10.1007/s40261-014-0238-6 ◽

2014 ◽

Vol 34 (12) ◽

pp. 845-855 ◽

Author(s):

Suman Wason ◽

David Mount ◽

Robert Faulkner

Keyword(s):

Single Dose ◽

Renal Impairment ◽

Renal Disease ◽

End Stage Renal Disease ◽

Open Label Study ◽

Label Study ◽

Stage Renal Disease ◽

Download Full-text

Single-Dose Pharmacokinetics of Ozanimod and its Major Active Metabolites Alone and in Combination with Gemfibrozil, Itraconazole, or Rifampin in Healthy Subjects: A Randomized, Parallel-Group, Open-Label Study

Advances in Therapy ◽

10.1007/s12325-020-01473-0 ◽

2020 ◽

Vol 37 (10) ◽

pp. 4381-4395

Author(s):

Jonathan Q. Tran ◽

Peijin Zhang ◽

Atalanta Ghosh ◽

Liangang Liu ◽

Mary Syto ◽

...

Keyword(s):

Single Dose ◽

Healthy Subjects ◽

Active Metabolites ◽

Open Label Study ◽

Label Study ◽

Download Full-text

Antibiotic prophylaxis and surgical site infections; a prospective open label study to clinically evaluate the serum and tissue concentration of single dose prophylactic ceftriaxone in laparoscopic cholecystectomy

European Journal of Clinical Pharmacology ◽

10.1007/s00228-020-02940-x ◽

2020 ◽

Author(s):

Salim Sheikh ◽

Neeraj Kumar Malik ◽

Bushra Ahmed Karim

Keyword(s):

Laparoscopic Cholecystectomy ◽

Single Dose ◽

Antibiotic Prophylaxis ◽

Tissue Concentration ◽

Surgical Site Infections ◽

Open Label Study ◽

Download Full-text

A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6–64 years who are considered to be at increased risk of pneumococcal disease and who are naive to pneumococcal vaccines

Vaccine ◽

10.1016/j.vaccine.2021.08.106 ◽

2021 ◽

Author(s):

Yoshitaka Yamazaki ◽

Masanori Ikeda ◽

Takayuki Imada ◽

Kenji Furuno ◽

Tomoyuki Mizukami ◽

...

Keyword(s):

Single Dose ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Pneumococcal Disease ◽

Pneumococcal Vaccines ◽

Phase 3 ◽

Open Label Study ◽

Label Study ◽

Download Full-text

Single-Dose, Open-Label Study of the Differences in Pharmacokinetics of Colchicine in Subjects with Renal Impairment, Including End-Stage Renal Disease

Clinical Drug Investigation ◽

10.1007/s40261-014-0262-6 ◽

2014 ◽

Vol 35 (2) ◽

pp. 149-149

Author(s):

Yalcin Solak ◽

Seyyid Bilal Acikgoz ◽

Mehmet Yildirim

Keyword(s):

Single Dose ◽

Renal Impairment ◽

Renal Disease ◽

End Stage Renal Disease ◽

Open Label Study ◽

Label Study ◽

Stage Renal Disease ◽

Download Full-text

An open‐label study to estimate the effect of steady‐state erythromycin on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban in subjects with renal impairment and normal renal function

The Journal of Clinical Pharmacology ◽

10.1002/jcph.352 ◽

2014 ◽

Vol 54 (12) ◽

pp. 1407-1420 ◽

Author(s):

Kenneth T. Moore ◽

Seema Vaidyanathan ◽

Jaya Natarajan ◽

Jay Ariyawansa ◽

Lloyd Haskell ◽

...

Keyword(s):

Renal Function ◽

Single Dose ◽

Steady State ◽

Renal Impairment ◽

Normal Renal Function ◽

Open Label Study ◽

Download Full-text

Single-dose pharmacokinetic properties of esomeprazole in children aged 1 – 11 years with endoscopically proven GERD: a randomized, open-label study

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cp201971 ◽

2014 ◽

Vol 52 (11) ◽

pp. 965-972 ◽

Author(s):

Nader N. Youssef ◽

Eduardo Tron ◽

Vasundhara Tolia ◽

Jennifer E. Hamer-Maansson ◽

Per Lundborg ◽

...

Keyword(s):

Single Dose ◽

Open Label Study ◽

Label Study ◽

Pharmacokinetic Properties

Download Full-text

Single Dose of Infliximab Is Safe and Effective in Severe Alcoholic Hepatitis: An Open Label Study

The American Journal of Gastroenterology ◽

10.14309/00000434-200709002-00343 ◽

2007 ◽

Vol 102 ◽

pp. S241

Author(s):

Praveen Sharma ◽

Ashish Kumar ◽

Ajay Kumar ◽

Hitendra Garg ◽

Barjesh C. Sharma ◽

...

Keyword(s):

Single Dose ◽

Alcoholic Hepatitis ◽

Open Label Study ◽

Label Study ◽

Severe Alcoholic Hepatitis

Download Full-text